Increased activation of the renin-angiotensin-aldosterone (RAAS) system is often associated with obesity and metabolic syndrome. We previously reported that aldosterone (aldo) produced by adipocytes regulate vascular function. Despite the fact that aldo production by adipocytes is increased in obesity, the role of aldo and its receptor, the mineralocorticoid receptor (MR), in the regulation of adipocytes biology and their downstream signaling remain elusive. Since Rho kinase (Rock) signaling has recently been implicated in the development of obesity, we tested the hypothesis that MR upregulation leads to dysregulation of adipokines through Rock-dependent mechanisms in obesity. Here we used obese db/db and lean db/+ mice, treated for 4 weeks...
Over the past decade, several studies have shown that activity of extra-renal mineralocorticoid rece...
The mineralocorticoid receptor (MR) acts as an essential regulator of blood pressure, volume status,...
The mineralocorticoid receptor (MR) was first identified as a blood pressure regulator, modulating r...
Increasing evidence indicates that adipose tissue modulates vascular function. Our previous studies ...
Abstract Activation of aldosterone/mineralocorticoid receptors (MR) has been implicated in vascular ...
Aldosterone (aldo) plays a role in obesity and cardiovascular diseases, such as hypertension. We pre...
The mineralocorticoid receptor (MR) classically mediates aldosterone effects on salt homeostasis and...
Mineralocorticoid receptor (MR) expression is increased in adipose tissue from obese individuals and...
Aldosterone controls blood pressure by binding to the mineralocorticoid receptor (MR), a ligand-acti...
Mineralocorticoid receptor (MR) expression is increased in adipose tissue from obese individuals and...
Metabolic syndrome is a major risk factor for the development of diabetes mellitus and cardiovascula...
Metabolic syndrome is a major risk factor for the development of diabetes mellitus and cardiovascula...
In addition to the well-documented role in the kidney, the mineralocorticoid receptor (MR) has been ...
Understanding the mechanisms linking obesity with hypertension is important in the current obesity e...
Increased visceral adiposity and hyperglycemia, two characteristics of metabolic syndrome, are also ...
Over the past decade, several studies have shown that activity of extra-renal mineralocorticoid rece...
The mineralocorticoid receptor (MR) acts as an essential regulator of blood pressure, volume status,...
The mineralocorticoid receptor (MR) was first identified as a blood pressure regulator, modulating r...
Increasing evidence indicates that adipose tissue modulates vascular function. Our previous studies ...
Abstract Activation of aldosterone/mineralocorticoid receptors (MR) has been implicated in vascular ...
Aldosterone (aldo) plays a role in obesity and cardiovascular diseases, such as hypertension. We pre...
The mineralocorticoid receptor (MR) classically mediates aldosterone effects on salt homeostasis and...
Mineralocorticoid receptor (MR) expression is increased in adipose tissue from obese individuals and...
Aldosterone controls blood pressure by binding to the mineralocorticoid receptor (MR), a ligand-acti...
Mineralocorticoid receptor (MR) expression is increased in adipose tissue from obese individuals and...
Metabolic syndrome is a major risk factor for the development of diabetes mellitus and cardiovascula...
Metabolic syndrome is a major risk factor for the development of diabetes mellitus and cardiovascula...
In addition to the well-documented role in the kidney, the mineralocorticoid receptor (MR) has been ...
Understanding the mechanisms linking obesity with hypertension is important in the current obesity e...
Increased visceral adiposity and hyperglycemia, two characteristics of metabolic syndrome, are also ...
Over the past decade, several studies have shown that activity of extra-renal mineralocorticoid rece...
The mineralocorticoid receptor (MR) acts as an essential regulator of blood pressure, volume status,...
The mineralocorticoid receptor (MR) was first identified as a blood pressure regulator, modulating r...